Weekly Roundup: In Case You Missed It

February 3, 2023

Medicare Changes: 2023 and Beyond

Cheryl Bradley, Associate Director of the CMA Center for Economic Services, joins us to review the policy changes for Medicare payments under the Physician Fee Schedule (PFS), and other Medicare Part B issues, effective for Calendar Year 2023 and beyond. This on demand webinar will provide you with the resources to help you maneuver regulatory and procedural challenges that impact your practice. Watch now. CME is available.

Applications Open for Loan Repayment Program

You can now submit your application for the CalHealthCares Loan Repayment Program. CalHealthCares provides loan repayment physicians who provide care to Medi-Cal patients. Eligible physicians can apply for an award of up to $300,000 in exchange for a five-year service obligation. The application deadline is March 3.

Evusheld Not Authorized for Use

Recently, the FDA revised the EUA for Evusheld (tixagevimab co-packaged with cilgavimab) and Evusheld is not currently authorized for use in the U.S. until further notice by the Agency. Data show Evusheld is unlikely to be active against certain SARS-CoV-2 variants. This action to limit the use of Evusheld prevents exposing patients to possible side effects of Evusheld such as allergic reactions, which can be potentially serious, at a time when fewer than 10% of circulating variants in the U.S. causing infection are susceptible to the product. 

Section 126 Application for Additional GME Slots Now Open

CMS announced the distribution of the first 200 GME slots, out of the additional 1,000 slots, that were created as part of the Consolidated Appropriations Act, 2021 (CAA). The slots will be effective July 1, 2023. The application cycle for the 200 FY 2024 slots is currently open and will remain open until March 31, 2023. In order to be eligible for these additional FTE resident cap slots, a hospital must qualify in at least one of the following four categories:   

  • Hospitals in rural areas (or treated as being located in a rural area under the law)  
  • Hospitals training a number of residents in excess of their GME cap  
  • Hospitals in states with new medical schools or branch campuses  
  • Hospitals that serve areas designated as health professional shortage areas (HPSAs) 

Medicare Physician Fee Schedule Updated

When Congress passed its year-end omnibus legislation in the final days of 2022, it included a 2% Medicare physician payment cut for 2023. As a result, the Centers for Medicare and Medicare Services (CMS) updated the 2023 conversion factor to $33.8872 for 2023. Noridian has now updated its 2023 Medicare Physician Fee Schedule to reflect this change and has started releasing 2023 claims for payment. 

Medi-Cal Rx Transition: Phase II Begins

Phase II of the DHCS Medi-Cal Rx transition began last Friday, January 20. In Phase II—which will be implemented in two waves—Medi-Cal Rx prescribers will again be required to submit prior authorizations (PAs) for the remaining drug classes. 

  • Phase II Wave 1 (January 20, 2023):  New start prescriptions in 39 drug classes 
  • Phase II Wave 2 (February 24, 2023): New start prescriptions in the remaining 21 drug classes. 

New start prescriptions for pediatric patients 21 years of age and under continue to be excluded to prevent additional administrative obligations for providers of specialty pediatric services who have been significantly impacted by the transition to Medi-Cal Rx. 

Quality Payment Program Exceptions: MIPS EUC Deadline Extended

CMS has extended the deadline to file a 2022 MIPS Extreme and Uncontrollable Circumstances (EUC) hardship extension until March 3, 2023. The original deadline was Jan 3, 2023. If physicians feel they have been impacted by the COVID-19 pandemic in 2022 they may file a MIPS hardship exemption with CMS to avoid a 2024 MIPS penalty. 

Risks to Patients Exposed to Xylazine in Illicit Drugs

Medi-Cal posted a reminder for physicians to continue to administer naloxone for opioid overdoses and consider xylazine exposure if patients are not responding to naloxone or when there are signs or symptoms of xylazine exposure (e.g., severe, necrotic skin ulcerations). Health care professionals should provide appropriate supportive measures to patients who do not respond to naloxone.

Create an Environmentally Sustainable Practice

ACCMA’s My Green Doctor program presents a free 40-minute on demand webinar offered by the American Medical Association. Watch the webinar yourself at any time and ask your office manager to watch as well to learn how easy it is to save money with environmentally sustainable practice management. Click here to claim CME after watching the webinar. My Green Doctor is a free money-saving membership benefit that allows medical offices to learn how to adopt environmental sustainability, save resources, and help create healthier communities. Visit My Green Doctor and register as a partner society member for full access to materials forever, for free. Use discount code MGDACCMA.  


Updates on the Legal Landscape in Post-Roe America and the Impact of the Dobbs Decision 

Wednesday, February 8 | Noon 

Free | Hosted by UC Health 


The University of California Health Systemwide Grand Grounds will review the current legal landscape, as well as considerations for health care providers and medical staff as they attempt to navigate this rapidly evolving post-Roe legal landscape. An overview of restrictive state laws' impact on medical education and women's health will also be provided. 


Register here

New 2023 E/M Coding, Billing, and Documentation Rules Impacting Your Practice 

Tuesday, February 21 | Noon to 1:00 pm 

Hosted by the Cooperative of American Physicians (CAP) 


This free webinar will address 2023 E/M coding and billing changes, led by renowned billing and coding expert Terry Fletcher. You and your staff will learn about updates to E/M billing, coding, and documentation rules, their impact on your patient care and reimbursements, and the steps you need to ensure that your practice is being appropriately reimbursed. 


Register here

New NP Classifications – What Physicians Need to Know 

Thursday, February 23 | 12:15 to 1:15 pm 

Hosted by CMA 


Assembly Bill 890 (Wood), signed into law in September 2020, created two new classifications of nurse practitioners (NPs) - 103 and 104 NPs - who can perform certain functions without standardized procedures and protocols in California. The regulations implementing the bill became effective as of January 1, 2023. These regulations set the minimum standards for the law’s "transition to practice" requirements for NPs seeking to apply for licensure under these classifications. NPs can elect, but are not required, to transition to these new classifications. This webinar will provide an overview of the law and regulations, explain under what circumstances 103 and 104 NPs can practice and where, and show how this may impact physicians and patients. 


Register here

49th Annual CMA Legislative Day 

Wednesday, April 19  


Join us for an all-day event in Sacramento to lobby legislators on priority health care issues. Members who join us will be provided an agenda that highlights all legislative meetings and talking points, so this is a great opportunity for first-timers to experience the legislative process in action.  


Click here to RSVP. 

Health IT: Powering Value-Based Care 

Monday, May 22 | 9:00 am to 4:00 pm 

Sacramento, CA | Free for CMA members 


Save the date for CMA’s first annual healt IT conference. The conference will bring together thought leaders from across California and the nation to explore the intersection of technology and payment reform. CMA expects a diverse set of attendees that will include physicians, medical groups and IPAs, health plans, health information organizations (HIOs) and others who will take the learnings from this conference to change how care is delivered in this state. 


Register here

ACCMA's On-Demand Library

To access all on-demand programs, go to https://www.pathlms.com/medical-society/courses 



Please contact ACCMA at 510-654-5383 or accma@accma.orgwith any questions or concerns you have.